arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 4/2013 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Lixisenatide (LYXUMIA): the third GLP-1 receptor agonist in type 2 diabetes

    New indication: tadalafil (CIALIS) against lower urinary tract symptoms secondary to benign prostatic hyperplasia

    a-t READER'S QUESTIONS AND COMMENTS

    Fumaric acid esters (FUMADERM) in psoriasis

    Buccal midazolam (BUCCOLAM) against seizures in children and adolescents

    New Data on pneumococcal vaccine in children

    IN BRIEF

    Antihistamine doxylamine approved for pregnant women experiencing nausea and vomiting

    Guideline against misleading and trivialising tradenames
    free

    SIDE EFFECTS

    Ophthalmic agents with phosphate buffers: corneal calcification

    New restrictions in the use of strontium ranelate (PROTELOS

    Cardiac harms and bleeding with cilostazol (PLETAL)

    GLP-1 based therapies damage the pancreas

    EMA recommends suspension of the marketing authorization of tetrazepam (MUSARIL, generics)

    e a-t IN INTERNET

    Vitamin C: risk of kidney stones increased

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles